Upload
lifetechlimburg
View
482
Download
0
Tags:
Embed Size (px)
Citation preview
Growing from a local company to a global player in the field of
minimal invasive biopsy
Interregio Network meeting: Internationalisation in life sciences
Diepenbeek (B),October 5th 2011
Click to edit Master title styleMedInvents’ concept
Personalized Medicine• Cytostatics• Hormones• Growth inhibitors• Monoclonal antibodies…
Personalized Diagnostics• Pathology• Immuno-histochemistry• Molecular biology…
Macrobiopsy•Enough tissue•Representative tissue• Fresh
Implementing clinical use of personalized diagnostics can stratify patients, give molecular classification of disease, determine the likelihood of occurrence, and recommend the best course of treatment. These approaches promise to reduce costs in healthcare,improve treatment, and have the potential to provide consumer-driven access to health information. But how will we acquire tissue to fulfill all these opportunities ? Cambridge Health-tech Institute (2011)
Click to edit Master title style
Anno 2011
Jaak Ph. Janssens New Direct and Frontal Tissue Acquisition Tools for Gene Expression Analysis. Current Pharmacogenomics & Personalized Medicine 2010; 8: 37-48
Powerful weapon
But where is the
ammunition ?
Click to edit Master title styleAbout Medinvents
Medinvents aims to be global leader of innovative products for minimal invasive biopsy. We provide a complete suite of biopsy devices needed to support healthcare providers in giving the best care to their patients. More and more targeted treatments are coming. Molecular biology is gaining importance. “Tissue is the issue ” for personalized diagnostics.
Our products are the solution for this new approach: a minimal invasive large core soft tissue biopsy with the highest level of accuracy and safety. Resulting in a fast and easy procedure with optimal diagnosis and better patient treatment.
Click to edit Master title styleOur Mission
-Input-Feasibility study (technical, medical, economical)-Requirement specification-Concept and alternative concepts-Detailed specification listing-Prototyping-Laboratory testing-Validation-Phase I, II, III, IV
-Patent approval-Raw materials exclusivity deals-Investor negotiations-Bank credits - loans-Social regulations-Manufacturing know-how-ISO certification 9001-2003-ISO certification 14385-National and Intn’l certificates-Research funding- Q3- 2004 Start Medinvents-Training – Audits– management…
- R&D and manufacturing -CE certification-FDA certification-Clinical studies – European – US Key Opinion Leaders-Liability insurance-Internal growth – additional investments – expanding research-Facilities-Legal aspects-Distribution network-Corporate imaging
From idea to concept From concept to product From product to market
2000 2001 2002 2003 2004 2005 2006 2007 2008 Go Live >>>
>>>
-General acceptation by the medical community-Return on investment-Market penetration-Reimbursement-Creation of alliances-OEM – original equipment manufacturing-Production automatization-Improvement of products - packaging-Intended use expansion-International Research Trials-Crossing the chasm- International base of KOL users
-Increase in clinical applications (brain, prostate,....) – Targeted Therapies –Molecular Biology-New diagnostic and therapeutic products with related IP. -Hybrid products, OEM expansion-Participation in robot development and manufacturing projects-Increase in consulting functions -Acquisition of manufacturing facilities-Acquisition of or participation in distribution groups-Increase in licensing agreements- From Local to Global
GOING LIVE The future
>>> Go Live 2009 2010 2011
Click to edit Master title styleMedinvents Product Groups
• Focus: Radiology & surgery• Soft tissue Biopsy Concept for higher quality & efficacy in personalized diagnostics• Manual or full automated systems• All Soft Tissue biopsies within clinical oncology
Spirotome & Coramate Systems
Click to edit Master title styleMedinvents Product GroupsSpirotome BONE & Spirotome SPINE
• Focus: Interventional Radiology & Orthopedics• Hybrid Biopsy Concept for bony & soft tissue structures• Specifically to be used in clinical situations where soft tissue from bony
structures (e.g osteolytic lesions) need a representative and high quality diagnostic biopsy
• From diagnostics to therapeutics trough Spirotome Spine Cross Bracing Vertebroplasty
Click to edit Master title styleMedinvents Product Groups
Spirotome CERIVCORE & Spirotome ENDO
• Focus: Gynecology & Endoscopy
• Colposcopic biopsies• Endoscopic or
laparoscopic staging of invasive cancers
Click to edit Master title styleMedinvents’ ApplicationsCoramate ™• Breast• Thyroid• Salivary glands• Thoracic wall• Abdominal wall• Lymph nodes• Muscle
Spirotome™• Breast• Thyroid• Salivary glands• Thoracic wall• Abdominal wall• Lymph nodes• Muscle• Liver• Lung
Spirotome Cervicore ™• Cervix• Uterus
Spirotome Easy Punch ™• Skin• Vulva
Spirotome Bone ™• Soft tissues within bone
Spirotome Endo ™• Laparoscopy (type ter Brugge)• Uterus (type Campo) Spirotome Neuro ™
• Brain
Spirotome Spine ™• Soft tissues within bone
Rad
iolo
gy
Gynecology
Orthopedics
Dermatology
Neurology
MedInvents’ technology superiority
1. Innovative technology2. Right in time for the
market3. Safety & Comfort4. Accuracy5. Product portfolio6. Strong science7. Patents & certificate8. Consistency9. Next generation
applications
• Direct & Frontal• Macrobiopsy• All soft tissues• Easy procedure• Less invasive
MedInvents’ technology superiority
1. Innovative technology2. Right in time for the
market3. Safety & Comfort4. Accuracy5. Product portfolio6. Strong science7. Patents & certificates8. Consistency9. Next generation
applications
Jaak Ph. Janssens New Direct and Frontal Tissue Acquisition Tools for Gene Expression Analysis. Current Pharmacogenomics & Personalized Medicine 2010; 8: 37-48
Molecular biology
MedInvents’ technology superiority
1. Innovative technology2. Right in time for the
market3. Safety & Comfort4. Accuracy5. Product portfolio6. Strong science7. Patents & certificates8. Consistency9. Next generation
applications
Ann Cornelis, Marcel Verjans, Thierry Van den Bosch, Katrien Wouters, Johan Van Robaeys, Jaak Ph. Janssens & Working Group on Hormone Dependent Cancers, The European Cancer Prevention Organization. Efficacy and safety of direct and frontal macrobiopsies in breast cancer. Eur J Cancer Prev 2009 ; 18 : 280 – 4.
MedInvents’ technology superiority
1. Innovative technology2. Right in time for the
market3. Safety & Comfort4. Accuracy5. Product portfolio6. Strong science7. Patents & certificates8. Consistency9. Next generation
applications
Gielen JL, De Schepper AM, Blom R, Van Dyck P, Bosmans JML, Creytens DH, Veryser J, Somville J, Parizel PM. Experience with a novel frontal core biopsy device in soft tissue and bone lesions.Skeletal Radiol 2011; 40 In press – Published online.
Harries R, Lawson S, Bruckers Liesbeth. Assessment of microcalcifications with limited number of high-precision macrobiopsies. Eur J Cancer Prev 2010; 19: 374-8.
MedInvents’ technology superiority
1. Innovative technology2. Right in time for the
market3. Safety & Comfort4. Accuracy5. Product portfolio6. Strong science7. Patents & certificates8. Consistency9. Next generation
applications
MedInvents’ technology superiority
1. Innovative technology2. Right in time for the
market3. Safety & Comfort4. Accuracy5. Product portfolio6. Strong science7. Patents & certificates8. Consistency9. Next generation
applicationsM, Barbaret V, Chiers K, Duchateau L, Bacci B, Terragni R, Rossi F, Sounders JH. Evaluation of a manual biopsy device («Spirotome ») on fresh canine organs : liver, spleen and kidneys and first clinical experience in animals. Eur J Cancer Prev 2010; 20:: 140-5.
MedInvents’ technology superiority
1. Innovative technology2. Right in time for the
market3. Safety & Comfort4. Accuracy5. Product portfolio6. Strong science7. Patents & certificate8. Consistency9. Next generation
applications
Ter Brugge H. Laparoscopic staging with a new direct and frontal biopsy instrument. J Gynecologic Surgery 2010; in press.
MedInvents’ technology superiority
1. Innovative technology2. Right in time for the
market3. Safety & Comfort4. Accuracy5. Product portfolio6. Strong science7. Patents & certificates8. Consistency9. Next generation
applications
• Proprietary technology• ISO 9001-2008• ISO 13485• FDA (13 applications)• Reimbursement
• Several applications• Several countries
MedInvents’ technology superiority
1. Innovative technology2. Right in time for the
market3. Safety & Comfort4. Accuracy5. Product portfolio6. Strong science7. Patents & certificates8. Consistency9. Next generation
applications
MedInvents’ technology superiority
1. Innovative technology2. Right in time for the
market3. Safety & Comfort4. Accuracy5. Product portfolio6. Strong science7. Patents & certificates8. Consistency9. Next generation
applications
Click to edit Master title styleMedinvents’ Marketing & SalesSales
Organisation
I n D i r e c t S a l e s
International expansion
Indirect Core
Countries
Indirect Countries
D i r e c t S a l e s
Medinvents Direct Sales
teamBeLux
Medinvents P r o j e c t s -
R & D
Consulting – Clincal Research
OEMR&D &
Manufacturing
Formal agreements in 10 countriesThe business is transferred to independent distributors who are trained and certified by MedInvents during an intensive training program.
The marketing in those countries is done by well chosen distributors supported directly by MedInvents.
Click to edit Master title style
1. Build a concept, not just a product2. Always be 1 step ahead – MedInvents = key to Molecular Biology3. Size doesn’t matter, quality & integrity does4. Direct sales on home markets for direct customer feedback 5. Succeed locally before you act globally6. Step-by-Step Expansion, be prepared7. Unique and extensive clinical liasons through partnerships with
international scientific associations (MSL – Medical Science Liaison)8. International partnerships with strong local networks 9. Continuous Training & Education 10. Be loyal to your Standards
Medinvents’ Tips & Tricks to succeed
Kuringersteenweg 304B-3500 Hasselt
tel: +32 (0)11 271557fax: +32 (0)11 283677
BE 0449 067 537
Thank you for your attention !
Medinvents 2011
Olivier WoutersChief Marketing & Sales
www.MedInvents.com